Skip to content
Retatrutide Guide

About · Disclosure

Affiliate disclosure

Some links on this site are affiliate links. This page explains what that means, how those links are marked, and the lines we do not cross.

Last updated: July 17, 2026.

The short version

Some outbound links on Retatrutide Guide are affiliate or sponsored links. If you follow one and later make a purchase or sign up with that partner, the site may earn a commission. The price you pay is the same whether you use our link or go directly — commissions are paid by the partner, not by you.

This disclosure exists to satisfy FTC requirements and, more importantly, because readers should never have to guess whether a link is commercial.

How affiliate links are marked

Every affiliate link on this site is rendered through a single component that always carries rel="sponsored nofollow noopener", so search engines and browsers can distinguish it from an editorial citation. Pages that contain affiliate links also identify them at the point of use — a link will never be commercial without saying so nearby.

What we will never link to

Retatrutide is an investigational drug. It is not approved anywhere and cannot be legally purchased. Accordingly, this site neverlinks to — and never earns commission from — gray-market or "research peptide" vendors, overseas compounders, or any other unregulated source of retatrutide. That rule is absolute and is not for sale.

Affiliate relationships are limited to legitimate, regulated services — for example, licensed telehealth providers offering clinician consultations for medications that are actually approved today.

Editorial independence

Commissions do not influence clinical content. Dosing data, side-effect profiles, trial results, and comparisons are written to the evidence and sourced per the editorial policy, which also lists what we refuse to publish. Commercial relationships are considered only after editorial content is written, and no partner reviews, approves, or sees clinical pages before publication.

The site accepts no payment, samples, consulting agreements, or content contributions from Eli Lilly, Novo Nordisk, or any other pharmaceutical manufacturer.

How we make money

Current and planned revenue sources, in plain terms:

  • Affiliate commissions — the mechanism described above, from clearly marked links to regulated partners.
  • Display advertising — may be introduced in the future; ad slots will be visually distinct from editorial content and will not use behavioral tracking (see the privacy policy).
  • Sponsorships— if ever accepted, they will be labeled "Sponsored" at the top of the affected placement, never embedded invisibly in clinical copy.

If none of these are active on a given page, that page carries no commercial links at all.

Questions

If a link on this site is ever unclear about its commercial status, treat that as a bug and report it via the contact page.